Chase AIPricingFAQs
Display currency
Loading news…

Intellect Neurosciences

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
New York, United States Founded 2005 1-10 employees For Profit

Intellect Neurosciences is engaged in the R&D of disease-modifying drugs for the prevention of neurological disorders such as Alzheimer's.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
0
Patents
5

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Delisted
Ticker
ILNS
Exchange
OTC Pink
IPO date
Sep 9, 2005
Delisted
Nov 30, 2018

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
3
Patents granted
5
Trademarks
0
Top patent class
Medical Or Veterinary Science; Hygiene

Company Info

Founded
2005
Employees
1-10
Operating status
Active
Company type
For Profit
Org types
company
News articles
1
HQ
New York, United States
Region
Greater New York Area, East Coast, Northeastern US
Exit date
Sep 9, 2005

Signals & Scores

Heat score
Low
Growth score
Low
Trend (7d)
-0.7
Trend (30d)
-1.5
Trend (90d)
3

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Intellect Neurosciences

Loading news…

FAQs about Intellect Neurosciences

People who checked this page also checked these

Browse the full Acquirezy directory.
Intellect Neurosciences - Company Profile, Full Acquisitions List, Funding and Investments